Literature DB >> 18586675

A common motif targets huntingtin and the androgen receptor to the proteasome.

Shweta Chandra1, Jieya Shao, Jennifer X Li, Mei Li, Frank M Longo, Marc I Diamond.   

Abstract

Huntington disease derives from a critically expanded polyglutamine tract in the huntingtin (Htt) protein; a similar polyglutamine expansion in the androgen receptor (AR) causes spinobulbar muscular atrophy. AR activity also plays an essential role in prostate cancer. Molecular mechanisms that regulate Htt and AR degradation are not well understood but could have important therapeutic implications. We find that a pentapeptide motif (FQKLL) within the Htt protein regulates its degradation and subcellular localization to cytoplasm puncta. Disruption of the motif by alanine substitution at the hydrophobic residues increases the steady state level of the protein. Pulsechase analyses indicate that the motif regulates degradation. A similar motif (FQNLF) has corresponding activities in the AR protein. Transfer of the Htt motif with five flanking amino acids on either side to YFP reduces the steady state YFP level by rendering it susceptible to proteasome degradation. This work defines a novel proteasome-targeting motif that is necessary and sufficient to regulate the degradation of two disease-associated proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18586675      PMCID: PMC2527109          DOI: 10.1074/jbc.M800467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

2.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 3.  The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor.

Authors:  Bin He; Elizabeth M Wilson
Journal:  Mol Genet Metab       Date:  2002-04       Impact factor: 4.797

4.  Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor.

Authors:  M I Diamond; M R Robinson; K R Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

5.  Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice.

Authors:  A Abel; J Walcott; J Woods; J Duda; D E Merry
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

Review 6.  Recent insights into the molecular pathogenesis of Huntington disease.

Authors:  B R Leavitt; C L Wellington; M R Hayden
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

7.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

8.  Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.

Authors:  Y J Kim; Y Yi; E Sapp; Y Wang; B Cuiffo; K B Kegel; Z H Qin; N Aronin; M DiFiglia
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

9.  HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration.

Authors:  Udai Bhan Pandey; Yakup Batlevi; Eric H Baehrecke; J Paul Taylor
Journal:  Autophagy       Date:  2007-09-10       Impact factor: 16.016

10.  Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.

Authors:  Toshiaki Takahashi; Shinya Kikuchi; Shinichi Katada; Yoshitaka Nagai; Masatoyo Nishizawa; Osamu Onodera
Journal:  Hum Mol Genet       Date:  2007-10-18       Impact factor: 6.150

View more
  10 in total

1.  Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells.

Authors:  Naoki Harada; Kaoru Inoue; Ryoichi Yamaji; Yoshihisa Nakano; Hiroshi Inui
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

2.  Flexible regions within I{kappa}B{alpha} create the ubiquitin-independent degradation signal.

Authors:  Erika Mathes; Lily Wang; Elizabeth Komives; Gourisankar Ghosh
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Defining an Embedded Code for Protein Ubiquitination.

Authors:  Trafina Jadhav; Marie W Wooten
Journal:  J Proteomics Bioinform       Date:  2009-07-24

4.  Analysis of interdomain interactions of the androgen receptor.

Authors:  Elizabeth M Wilson
Journal:  Methods Mol Biol       Date:  2011

5.  An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.

Authors:  Christopher R Orr; Heather L Montie; Yuhong Liu; Elena Bolzoni; Shannon C Jenkins; Elizabeth M Wilson; James D Joseph; Donald P McDonnell; Diane E Merry
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

6.  AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localization.

Authors:  Jeremy O Jones; W Frank An; Marc I Diamond
Journal:  ACS Chem Biol       Date:  2009-03-20       Impact factor: 5.100

7.  Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.

Authors:  Emily B Askew; Suxia Bai; Andrew T Hnat; John T Minges; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2009-10-14       Impact factor: 5.157

8.  Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.

Authors:  Mara P Steinkamp; Orla A O'Mahony; Michele Brogley; Haniya Rehman; Elizabeth W Lapensee; Saravana Dhanasekaran; Matthias D Hofer; Rainer Kuefer; Arul Chinnaiyan; Mark A Rubin; Kenneth J Pienta; Diane M Robins
Journal:  Cancer Res       Date:  2009-04-14       Impact factor: 12.701

9.  Mouse models of Huntington disease: variations on a theme.

Authors:  Dagmar E Ehrnhoefer; Stefanie L Butland; Mahmoud A Pouladi; Michael R Hayden
Journal:  Dis Model Mech       Date:  2009 Mar-Apr       Impact factor: 5.758

10.  PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model.

Authors:  Alisia Carnemolla; Silvia Michelazzi; Elena Agostoni
Journal:  Front Cell Neurosci       Date:  2017-05-08       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.